Literature DB >> 25495764

In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.

Bonto Faburay1, Dongseob Tark, Anumantha G Kanthasamy, Juergen A Richt.   

Abstract

Protein misfolding cyclic amplification (PMCA) is an in vitro simulation of prion replication, which relies on the use of normal brain homogenate derived from host species as substrate for the specific amplification of abnormal prion protein, PrP(Sc). Studies showed that recombinant cellular PrP, PrP(C), expressed in Escherichia coli lacks N-glycosylation and an glycophosphatidyl inositol anchor (GPI) and therefore may not be the most suitable substrate in seeded PMCA reactions to recapitulate prion conversion in vitro. In this study, we expressed 2 PRNP genotypes of sheep, V136L141R154Q171 and A136F141R154Q171, and one genotype of white-tailed deer (Q95G96, X132,Y216) using the baculovirus expression system and evaluated their suitability as substrates in seeded-PMCA. It has been reported that host-encoded mammalian RNA molecules and divalent cations play a role in the pathogenesis of prion diseases, and RNA molecules have also been shown to improve the sensitivity of PMCA assays. Therefore, we also assessed the effect of co-factors, such as prion-specific mRNA molecules and a divalent cation, manganese, on protein conversion. Here, we report that baculovirus-expressed recombinant PrP(C) shows a glycoform and GPI-anchor profile similar to mammalian brain-derived PrP(C) and supports amplification of PrP(Sc) and PrP(CWD) derived from prion-affected animals in a single round of seeded PMCA in the absence of exogenous co-factors. Addition of species-specific in vitro transcribed PrP mRNA molecules stimulated the conversion efficiency resulting in increased PrP(Sc) or PrP(CWD) production. Addition of 2 to 20 μM of manganese chloride (MnCl2) to unseeded PMCA resulted in conversion of recombinant PrP(C) to protease-resistant PrP. Collectively, we demonstrate, for the first time, that baculovirus expressed sheep and deer PrP can serve as a substrate in protein misfolding cyclic amplification for sheep and deer prions in the absence of additional exogenous co-factors.

Entities:  

Keywords:  PrPSc, PrPCWD; PrPres; prion; protein misfolding cyclic amplification; recombinant PrPC

Mesh:

Substances:

Year:  2014        PMID: 25495764      PMCID: PMC4601224          DOI: 10.4161/19336896.2014.983753

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  58 in total

1.  Identification of multiple quantitative trait loci linked to prion disease incubation period in mice.

Authors:  S E Lloyd; O N Onwuazor; J A Beck; G Mallinson; M Farrall; P Targonski; J Collinge; E M Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.

Authors:  Christopher J Choi; Vellareddy Anantharam; Dustin P Martin; Eric M Nicholson; Jürgen A Richt; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2010-02-22       Impact factor: 4.849

3.  Glycosylphosphatidylinositol anchor-dependent stimulation pathway required for generation of baculovirus-derived recombinant scrapie prion protein.

Authors:  Morikazu Imamura; Nobuko Kato; Miyako Yoshioka; Hiroyuki Okada; Yoshifumi Iwamaru; Yoshihisa Shimizu; Shirou Mohri; Takashi Yokoyama; Yuichi Murayama
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

4.  Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods.

Authors:  G M Shaked; Z Meiner; I Avraham; A Taraboulos; R Gabizon
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

5.  Prion glycoprotein: structure, dynamics, and roles for the sugars.

Authors:  P M Rudd; M R Wormald; D R Wing; S B Prusiner; R A Dwek
Journal:  Biochemistry       Date:  2001-04-03       Impact factor: 3.162

6.  Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro.

Authors:  Nathan R Deleault; Richard Kascsak; James C Geoghegan; Surachai Supattapone
Journal:  Biochemistry       Date:  2010-05-11       Impact factor: 3.162

7.  Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors.

Authors:  Jae-Il Kim; Ignazio Cali; Krystyna Surewicz; Qingzhong Kong; Gregory J Raymond; Ryuichiro Atarashi; Brent Race; Liuting Qing; Pierluigi Gambetti; Byron Caughey; Witold K Surewicz
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

Review 8.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays.

Authors:  Jason M Wilham; Christina D Orrú; Richard A Bessen; Ryuichiro Atarashi; Kazunori Sano; Brent Race; Kimberly D Meade-White; Lara M Taubner; Andrew Timmes; Byron Caughey
Journal:  PLoS Pathog       Date:  2010-12-02       Impact factor: 6.823

10.  The role of glycophosphatidylinositol anchor in the amplification of the scrapie isoform of prion protein in vitro.

Authors:  Jae-Il Kim; Krystyna Surewicz; Pierluigi Gambetti; Witold K Surewicz
Journal:  FEBS Lett       Date:  2009-10-23       Impact factor: 4.124

View more
  2 in total

1.  Comparative analysis of heparin affecting the biochemical properties of chicken and murine prion proteins.

Authors:  Li-Juan Wang; Xiao-Dan Gu; Xiao-Xiao Li; Liang Shen; Hong-Fang Ji
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

2.  In Vitro Approach To Identify Key Amino Acids in Low Susceptibility of Rabbit Prion Protein to Misfolding.

Authors:  Hasier Eraña; Natalia Fernández-Borges; Saioa R Elezgarai; Chafik Harrathi; Jorge M Charco; Francesca Chianini; Mark P Dagleish; Gabriel Ortega; Óscar Millet; Joaquín Castilla
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.